Preferred Label : Pegzilarginase;
NCIt synonyms : Pegylated Recombinant Arginase AEB1102; Co-ArgI-PEG;
NCIt definition : A recombinant modified form of the human enzyme arginase 1 (ARG1), in which cobalt
is substituted for manganese as a cofactor, covalently attached to polyethylene glycol
(PEG), with potential arginine degrading and antineoplastic activities. Upon intravenous
administration of pegzilarginase, ARG1 metabolizes the amino acid arginine to ornithine
and urea, thereby lowering blood arginine levels. This normalizes blood arginine levels
in patients with ARG1 deficiency and prevents hyperargininemia. This also inhibits
the proliferation of cancer cells that are dependent on extracellular arginine uptake
for their proliferation. In normal, healthy cells, arginine is synthesized intracellularly
by the enzymes ornithine transcarbamylase (OTC), argininosuccinate synthase (ASS),
and argininosuccinate lyase (ASL); thus they are not dependent on extracellular arginine
for survival. In cancer cells these enzymes are disabled; therefore, this agent may
inhibit proliferation and survival of these cells by depleting extracellular arginine.
Pegylation improves blood circulation times and cobalt substitution increases the
catalytic activity of ARG1.;
UNII : 4YV4KW88GD;
CAS number : 1659310-95-8;
Molecule name : AEB-1102;
NCI Metathesaurus CUI : CL503972;
Origin ID : C125143;
UMLS CUI : C4724814;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
concept_is_in_subset
https://www.has-sante.fr/jcms/p_3516966/fr/loargys-pegzilarginase-deficit-en-arginase-1
2024
false
false
false
France
ARG1 protein, human
insurance, health, reimbursement
treatment outcome
orphan drug production
package leaflet
summary of product characteristics
adult
pegzilarginase
adolescent
child
guidelines for drug use
enzyme replacement therapy
continuity of patient care
evaluation of the transparency committee
hyperargininemia
Arginase-1
Pegzilarginase
---
https://ansm.sante.fr/tableau-marr/pegzilarginase
2024
false
false
false
France
French
risk management
Pegzilarginase
pegzilarginase
drug information
patients guideline
medication errors
Pegzilarginase
drug hypersensitivity
injections, subcutaneous
home nursing
---
https://ansm.sante.fr/tableau-acces-derogatoire/pegzilarginase
2024
false
false
false
France
French
drug information
insurance, health, reimbursement
Pegzilarginase
enzyme replacement therapy
pegzilarginase
hyperargininemia
arginase
adult
adolescent
child
---
https://www.ema.europa.eu/en/medicines/human/EPAR/loargys
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Pegzilarginase
Pegzilarginase
pegzilarginase
enzyme replacement therapy
drug approval
europe
hyperargininemia
orphan drug production
child
adolescent
adult
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
infusions, intravenous
injections, subcutaneous
---